bioRxivBiophysics
Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
C. D. Hodge, D. J. Rosenberg, M. Wilamowski, A. D. Joachimiak, G. L. Hura, M. Hammel
Abstract
Monoclonal antibodies (mAbs) are the basis of treatments and diagnostics for pathogens and other biological phenomena. We conducted a structural characterization of mAbs against the N-terminal domain of nucleocapsid protein (NPNTD) from SARS-CoV-2 using small angle X-ray scattering (SAXS). Our solution-based results distinguished the mAbs flexibility and how this flexibility impacts the assembly of multiple mAbs on an antigen. By pairing two mAbs that bind different epitopes on the NPNTD, we show that flexible mAbs form a closed sandwich-like complex. With rigid mAbs, a juxtaposition of the Fabs is prevented, enforcing a linear arrangement of the mAb pair, which facilitates further mAb polymerization. In a modified sandwich ELISA, we show the rigid mAb-pairings with linear polymerization led to increased NPNTD detection sensitivity. These enhancements can expedite the development of more sensitive and selective antigen-detecting point-of-care lateral flow devices (LFA), key for early diagnosis and epidemiological studies of SARS-CoV-2 and other pathogens.
- assay: protein structure
- research focus: host-pathogen & immune response
- approach: experimental assay
- approach: microscopy & imaging analysis
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies
Q. Ye, S. Lu, K. D. Corbett·bioRxiv·Jun 1, 2021
- Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
Wajihul Hasan Khan, Nida Khan, … Anurag Singh Rathore·International Journal of Biological MacromoleculesPeer-reviewed·Jan 17, 2022
- Brief Communication: Magnetic Immuno-Detection of SARS-CoV-2 specific Antibodies
Jan Pietschmann, Nadja Voepel, … Florian Schröper·bioRxiv·Jun 2, 2020
- Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
J. S. Terry, L. B. Anderson, … B. J. Geiss·bioRxiv·Sep 3, 2020
- Nanoparticle-Supported, Rapid, Digital Quantification of Neutralizing Antibodies Against SARS-CoV-2 Variants
Seyedsina Mirjalili, Md Ashif Ikbal, … Chao Wang·Biosensors and BioelectronicsPeer-reviewed·Nov 6, 2024
- Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
C. Fan, A. A. Cohen, … P. J. Bjorkman·bioRxiv·Jun 28, 2022